Theralase Technologies Inc. V.TLT

Good discussion boys

[Rumpl3StiltSkin]

It definetly jogged my memory on What's necessary for BTD and AA submission.

[Rumpl3StiltSkin]

It has always been 20-25 patient data at 450 days for this study 2. So has this changed? For either BTD or AA? If not then the cohorts BF, FGP and Poop, are they all the same person? Are full of it. TLT has this data whether looking at the old data or the optimized data. So.....

[DJDawg]

I think that 20-25 patient data threshold is out of date. I believe that when they had the 2/3 CR's in the phase 1b they were told that IF the data continues to look this good over time then 25 patients would be sufficient. 66% CR carried forward to 450 days would be good enough. Then came the undertreated patients and the CR's changed so all bets were off.

[Johnandrose22]

I will be keenly focused on the company's next NR...no matter how significant/insignificant the headline might be. I will be reading every word, every letter in the commentaries of Dr. Mandel and Mr. White regarding the status of this company. 2024 will mark 10 years for me without a dime of return....I'm getting tired. John

[Infinity]

John and Rose, I get it, I am with you on this.  It has been nearly 10 years for me as well.  I first got interested in 2013 after a run-in with Dr. Jewet at PMH. 

[Pandora]

As they say --- you're not alone!

[Tapps21]

Here's my take. I have been here one heck of a long time. Reading most writers posts. The sensible ones at least. It's amazing how each writer interprets each NR and the comments made by the company, from the CEO down. But I guarantee each and every one of you most of us do not have a clue. Yes we can speculate but what goes on and what is actually happening behind those four walls only

[BudFoxx2020]

I really feel for investors like this.  I am just going to be 100% honest.  Your money is gone.  I have been in the markets almost 25 years now.  I started very young in high school.  I have seen it all and been through it all.  I really wish I was wrong.  But I have seen this type of play so many times.  I wish you all the best.  At the end of they day

[skier59]

Ok Bud, why dont you STFup and respect your word. I don't need to read your daily bashing of this stock that has hurt me more than you can imagine !!! You said a few days ago you were done and would be back in 2024. You are worse than the pumpers and obviously don't even respect your word or morals! Let the board be in peace as you say, or are you just another BS poster trying to

[BudFoxx2020]

Since I know your history here skier I will address your post this one time.  I only posted today because I saw some new filing by TLT and it came up on my screener.  I found it very interesting  to read and All I did was share the news and the same suspect came all out to attack me.  As if I wrote that filing myself.  If anything Skier you should be glad I posted it, the

[Donein25]

No one here cares what you say Buddy boy. No one. Good bye Foxx. 

[O12009]

The only way I see the id--- post is you make it a discussion instead of a comment ,please put him on ignore.  thanks

[Rumpl3StiltSkin]

Let's be clear here, they now have 40% CR+IR optimized patient data on 33 patients. @ 450days. They can submit BTD as soon as they have the data FDA requested. Which they may have at this time.38% CR+IR Dara @450 days on the non optimized group of ~40 patients. Pretty good %s and significantly better than keytruda. Ruvdar has few side effects and is a monmo treatment.

[Benedictus]

Once again dawg your insights fill in some of my confusion gaps with this investment and why the BTD timeline was pushed out. So, this is far less about FDA goal posts moving and more about not obtaining similar results to ph 1b. Even if we consider just the optimized cohort of 32 patients treated, while the results are very good they fall short of that very high bar. But with so much collected

[Oilminerdeluxe]

We should have some money soon then. Any idea how much a GBM study might cost? I assume it will be a while until it happens. Lets just hope that freaking financing gets filled. I find it odd it went so muuh lower than the financing price, but it should bounce back once closed one would think

[Rumpl3StiltSkin]

TLT just got a. Canabinoid patent. I'm guessing they want to use that for a GBM phase 1? Do they have a Cannabis company in mind to partner with? Many Cannabis companies are flush with cash and would love to branch into medical. A small Canada based phase 1 might not cost that much and will allow them to dive into the world of solid tumors. IMO.

[Oilminerdeluxe]

Yjanks, Rump

[Oilminerdeluxe]

Thanks

[Rumpl3StiltSkin]

I'm sorry but what dawg said in this earlier post is misleading. First, the delai IS due to TLT wanting to go with optimized data, where they didnt have 25 of those until earlier this year. Next up is that 66% figure. Which was the phase 1 number and killer if maintained through phase 2. But not necessary as Dr. K said 30% CR would be GREAT!  So TLT is in fine shape for BTD if they can